INvestigating DIGital Outcomes in the Community

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

20000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-12-01

Study Completion Date

2025-06-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To explore the feasibility and best methodology for collecting patient-reported outcome measures in patients who have previously been treated for cancer and are living in the community.

The investigators are working with primary care research teams, and using an online electronic questionnaire. Although the study is entirely observational, the study offers some of the questions in a random order, so the investigators can explore the effect of changing the way in which questions are asked.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Digital Monitoring in Cancer Survivors

NCT06669832

Cancer

RECRUITING

Assessing Patient-reported & Patient-related Outcomes in Randomized Cancer Trials for Older Adults

NCT03676218

Cancer

COMPLETED

A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer

NCT05053230

Head and Neck Cancer Head and Neck Tumor Thoracic Tumor +5 more

RECRUITING NA

Improving Care Pathway Using Simplified Digital Tools for Oncology Patients: a Multicenter "Before-and-after" Study

NCT05968027

Oncology Adverse Event Numeric Application +3 more

UNKNOWN

Electronic Patient Reporting of Symptoms and Unmet Needs to Connect Patients With Advanced Cancer to Palliative Care Services

NCT07195513

Palliative Care Referral Advanced Cancer Palliative Care, Health Services +1 more

NOT_YET_RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

INDIGO Community aims to both collect data on patient-reported outcome measures (PROMS) and patient-reported experience measures (PREMS) and data on the impact of how to do this.

The focus is on adult patients living in the community who have previously been treated for cancer.

The study uses a range of quality of life questionnaires, and randomises the order in which some questions are asked, in order to explore the impact of how questions are asked on responses.

All patients with be offered the EuroQol 5 dimension, 5 level questionnaire (EQ5D-5L)

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

ECOLOGIC_OR_COMMUNITY

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Different PROM Completion rate

Patients will be randomised to two different PROM questionnaires

The outcome measure will be the completion rate of the two different questionnaires

No interventions assigned to this group

Linked to national data

Patients will be randomly assigned to be asked to link personal data with national cancer data.

The outcome measure will be the proportion of completed questionnaires

No interventions assigned to this group

Linking to national data, early vs. late questions

Subset of cohort 1: Patients will be randomly assigned to be asked the question about data linkage at the beginning vs. end of the questionnaire

The outcome measure will be the proportion answering yes in each arm

No interventions assigned to this group

Impact of additional PROMS on completion and satisfaction

Patients will be randomised to either a standard PROM or additional, symptom directed questionnaire

The outcome measure will be the satisfaction rate of patients in each arm

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Participants who self-identify as having previously (time unlimited) received a diagnosis of cancer, based on histological, radiological, or clinical grounds (primary and/or metastatic cancer). Current treatment is not a barrier to participation, but the emphasis is on patients who have completed treatment.

Participants need to be able to access the secure online platform, using a mobile device or computer.

* Have capacity and be able to provide informed consent via the online platform.
* To be able to understand, read and write English, with or without support from a trusted individual e.g., friends, family, carer.

Exclusion Criteria

* Participants recently diagnosed with cancer (less than 12 months ago).
* Participants unable to access secure online platform.
* Participants who do not have sufficiently good understanding of written English to complete the PROMs and are unable to be supported by a trusted individual to complete the questionnaire.
* Participants lacking capacity and unable to give informed consent.

Minimum Eligible Age

16 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No